Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study
Go back to Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study| (NYSE: RCUS) | Delayed: 24.31 +0.19 (0.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.12 | 52 Week High | $ | |||
| Open | $24.50 | 52 Week Low | $ | |||
| Day High | $24.84 | P/E | N/A | |||
| Day Low | $23.80 | EPS | $ | |||
| Volume | 2,309,066 | |||||
